c. difficile infection Videos
-
Destiny Pharma consultant Professor Dale Gerding updates on recurrent C. difficile infections work - Video
Destiny Pharma's key consultant and member of the Scientific Advisory Board Professor Dale Gerding provides an update on microbiome therapeutic NTCD-M3 for recurrent C. difficile infections. The NTCD-M3 programme targets the prevention of the recurrence of clostridium difficile infection and has been developed through the world leading research of Professor Dale ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you